Clinical Nephrology and Urology Science

Clinical Nephrology and Urology Science

ISSN 2054-7161

Review of renal artery embolization for treatment of renal angiomyolipoma

Melvin Omodon1*, Gloria Ayuba2 and Indravadan J. Patel3

*Correspondence: Melvin Omodon

1. Aultman Hospital, 2600 6th St SW, Canton, OH 44710, USA.

Author Affiliations

2. Beaumont Hospital- Dearborn MI 48124, USA.

3. Assistant Professor, Radiology, CWRU School of Medicine Cleveland, Ohio, USA.


Renal angiomyolipoma (AML) is a benign renal neoplasm with the exception of the rare epithelioid variant. AML may be sporadic or may be associated with tuberous sclerosis complex or pulmonary lymphangioleiomyomatosis. Risk of hemorrhage is the concern for patients with AML. Renal artery embolization (RAE) is the treatment of choice for acute hemorrhage from angiomyolipoma, and also firstline prophylactic treatment for angiomyolipomas at risk of bleeding. This article reviews the prevalence of AML, factors associated with risk of hemorrhage, and the role of RAE in treatment of these patients.

Keywords: Angiomyolipoma, renal artery embolization, renal neoplasm, acute renal bleed, lymphangioleiomyomatosis, tuberous sclerosis, post-embolization syndrome

ISSN 2054-7161
Volume 3
Abstract Download